Chaudhri Saurabh, Thomas Alice A, Samad Nasreen, Fan Stanley L
Department of Renal Medicine and Transplantation, Barts Health NHS Trust, London, UK.
Nephrology (Carlton). 2018 Feb;23(2):162-168. doi: 10.1111/nep.12951.
To determine if patients with failing kidney transplants who opt to have peritoneal dialysis (PD) have poor short-term PD technique survival and increased rates of peritonitis.
We performed a retrospective analysis comparing 50 consecutive patients starting PD after a failed kidney transplant to 93 incident patients starting PD (matching for age, gender, diabetes causing renal failure, ethnicity and year of starting PD).
The mean follow-up period was 26 months. PD technique survival was lower for the post-transplant cohort. However, this did not appear to be related to PD peritonitis risk; infection rate was lower in the post-transplant group albeit not statistically significant (1 in 23.6 patient months vs 1 in 22.5 patient months). There were no differences in the proportion of Gram positive: Gran negative: Culture Negative infections. The only fungal peritonitis occurred in a Control patient. Results of baseline Peritoneal Equilibration Tests were not different; D/Pcr was 0.69 for post-TP versus 0.64 for Control (P = ns), and net UF was 250 mL for post-TP versus 310 mL for Control (P = ns). PET results after 12 months were also similar.
Our study found a small but significantly higher rate of PD technique failure in the post-transplant cohort, but this did not appear to be related to peritonitis rates or peritoneal membrane function. Further studies are required to explore reasons for PD technique failure in patients who have had kidney transplant, but our study supports the use of PD in selected patient from this cohort.
确定选择腹膜透析(PD)的肾移植失败患者是否短期腹膜透析技术存活率低且腹膜炎发生率增加。
我们进行了一项回顾性分析,将50例肾移植失败后开始腹膜透析的连续患者与93例开始腹膜透析的初发患者(按年龄、性别、导致肾衰竭的糖尿病、种族和开始腹膜透析的年份匹配)进行比较。
平均随访期为26个月。移植后队列的腹膜透析技术存活率较低。然而,这似乎与腹膜透析腹膜炎风险无关;移植后组的感染率较低,尽管无统计学意义(每23.6患者月1例 vs 每22.5患者月1例)。革兰氏阳性:革兰氏阴性:培养阴性感染的比例没有差异。唯一的真菌性腹膜炎发生在一名对照患者中。基线腹膜平衡试验结果无差异;移植后组的D/Pcr为0.69,对照组为0.64(P = 无统计学意义),移植后组的净超滤量为250 mL,对照组为310 mL(P = 无统计学意义)。12个月后的PET结果也相似。
我们的研究发现移植后队列中腹膜透析技术失败率虽小但显著更高,但这似乎与腹膜炎发生率或腹膜功能无关。需要进一步研究探索肾移植患者腹膜透析技术失败的原因,但我们的研究支持在该队列的特定患者中使用腹膜透析。